Drug intelligence / Profile preview

VLCD formula 2

Development stage: Unknown
Lead developer: Oluf Mørk A/S
Modality: Small Molecules
Administration: Oral

Overview

VLCD formula 2 is a specific very low-calorie diet (VLCD) formula designed for significant weight loss and the potential remission of type 2 diabetes. This particular formulation is characterized by a high-fiber, high-protein, low-carbohydrate, and low-fat macronutrient profile, providing a restricted caloric intake typically ranging from 600-800 kcal/day. It functions as a nutritional product to induce metabolic changes beneficial for managing type 2 diabetes.

Other names: high-fiber, high-protein, and low-carb, low-fat formula diet

Beyond the preview

Go deeper on VLCD formula 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VLCD formula 2.

Explore the full profile